The global Pharmaceutical Pellets Market Size is valued at 1.97 billion in 2023 and is predicted to reach 4.43 billion by the year 2031 at a 10.75% CAGR during the forecast period for 2024-2031.
Pellets or granules are free-flowing units created by agglomeration processes in capsules. Fine powders are transformed into fine particles using agglomeration processes. Compared to alternative dosage forms, these particles have various advantages, including the ability to administer multiple medications in a single dose, disguise the desired drug aftertaste, and improve patient compliance with drug administration.
Furthermore, medication pellets have a wide range of applications in the pharmaceutical industry since they can improve the appearance of drugs and are compatible with chemically incompatible drugs. The rising prevalence of chronic disorders is propelling the pharmaceutical pellets industry forward. Furthermore, increased government spending on healthcare programs and infrastructure is supporting the expansion of the pharmaceutical pellet market.
However, the COVID-19 pandemic has impacted every other industry's supply chain. The healthcare industry is expected to rise by double digits by 2025. This, in turn, has offered attractive prospects for new entrants and emerging market players.
Recent Developments:
- In March 2023, Colorcon Corporation purchased Arsenal Capital Partners' Airnov Healthcare Packaging. Colorcon's stability and moisture management solutions platform is being extended from its core to encapsulated and packaged products as a result of the partnership. Colorcon's purchase underlines the company's goal of investing in and empowering innovative solutions that enable health and wellness product manufacturers to reduce time to market while improving quality and competitiveness.
Competitive Landscape:
Some of the Pharmaceutical Pellets Market players are:
- Abbott Laboratories
- Avanscure Lifesciences Private Limited
- Concord Drugs Limited
- Chemit Laboratories
- Colorcon Inc.
- Lograns Pharma Private Limited
- MB Sugars & Pharmaceuticals Limited
- Manus Aktteva Biopharma LLP
- Nanjing Joyfulchem Co. Ltd.
- Nordic Sugar
- Nami Pharma
- Pharmaceuticals Private Limited
- Rainbow Health Care Products
- Thexa Pharma (P) Limited
- U.K. Vet Chem
Market Segmentation:
The Pharmaceutical Pellets Market is segmented on the basis of technology and mechanism of action. The Technology segment includes dry powder layering, extrusion, fluid bed granulation, solution & suspension layering, spray congealing, and spray drying. The mechanism of action segment includes diffusion, erosion, and osmosis.
Based On Technology, The Extrusion Segment Is Accounted As A Major Contributor To The Pharmaceutical Pellets Market
The extrusion category is expected to hold a major share of the global Pharmaceutical Pellets Market in 2024. Extrusion is one of the most used methods for producing pellets. Extrusion is a multi-stage process that produces uniform-sized pellets. Dry mixing to achieve homogeneity is one of the key steps, followed by wet mixing to form an appropriate plastic mass. Another recent method that has gotten a lot of interest in solution and suspension layering. The pellets or particles are formed consistently in this procedure, resulting in excellent surface morphology. The solutions and suspension layering category has grown over time, contributing to the expansion of its market share.
The Diffusion Segment Witnessed Growth At A Rapid Rate
The diffusion segment is projected to grow at a rapid rate in the global pharmaceutical pellets market. It is the most often utilized method for releasing drugs from pellets. Diffusion is the most precise and effective technique for the creation of medicinal pellets. Over the projected period, the osmosis segment is expected to grow steadily and profitably.
In The Region, The North American Pharmaceutical Pellets Market Holds A Significant Revenue Share
The North America Pharmaceutical Pellets Market is expected to register the most increased market share in terms of revenue shortly. Pharmaceutical pellets market expansion is being fueled by the rise in R&D activities in the pharmaceutical sector as well as rising expenditure on healthcare infrastructure. Because of the growing number of elderly individuals, the Asia Pacific area is predicted to develop rapidly during the projection period. Furthermore, increased government investments to improve the country's healthcare environment boost market growth. Meanwhile, the growing availability of biopharmaceuticals is driving market expansion in the region.
Pharmaceutical Pellets Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 1.97 Bn |
|
Revenue Forecast in 2031 |
USD 4.43 Mn |
|
Growth rate CAGR |
CAGR of 10.75% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments Covered |
Technology And Mechanism of Action |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Abbott Laboratories, Avanscure Lifesciences Private Limited, Concord Drugs Limited, Chemit Laboratories, Colorcon Inc., Lograns Pharma Private Limited, MB Sugars & Pharmaceuticals Limited, Manus Aktteva Biopharma LLP, Nanjing Joyfulchem Co. Ltd., Nordic Sugar, Nami Pharma, Pharmaceuticals Private Limited, Rainbow Health Care Products, Thexa Pharma (P) Limited, and U.K. Vet Chem. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
